GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, GLRA1, HSD17B2, IGF1R, MMP2, MMP9, PPARA, PPARD, RORC, SRC, TYR |
9.13139 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADORA2A, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, PPARD, RORC, SRC, TERT, TYR |
8.8999 |
[BP] GO:0010033 |
response to organic substance
|
ADORA2A, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, HSD17B2, IGF1R, KDR, MMP2, PPARA, PPARD, RORC, SRC, TYR |
8.7454 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
8.66939 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
8.1894 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADORA2A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
8.1894 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
8.08889 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, GLRA1, KDR, MMP9, SRC, TERT |
8.01066 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARD, SRC, TERT, XDH |
7.55921 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
7.53273 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, HCAR2, IGF1R, KDR, MMP9, PIM1, PPARD, PTPN1, SRC, TERT, TOP2A, XDH |
7.46392 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GLRA1, IGF1R, KDR, MMP2, MMP9, PPARD, RORC, SRC, TERT |
6.7963 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
6.7963 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.77082 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GLRA1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
6.77005 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B2, PPARD |
6.77005 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARD, PTPN1, SRC, TERT |
6.68302 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PPARD, RORC, SRC, TYR |
6.61436 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ADORA2A, ALPL, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, RORC, SRC, TYR |
6.58639 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A2, DNMT1, ESR1, ESRRA, FABP3, FLT3, GLRA1, IGF1R, MMP2, PPARA, SRC |
6.49943 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARD, PTPN1, SRC, TERT |
6.43276 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GLRA1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
6.29462 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARD, RORC, SRC, TERT, TOP2A, TYR |
6.29351 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GLRA1, HCAR2, HSD17B1, HSD17B2, KDR, MET, PPARA, PPARD, SRC, TERT, XDH |
6.29351 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
6.16391 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
6.14147 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, HSD17B1, HSD17B2, MET, PPARA, PPARD |
6.04945 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GLRA1, IGF1R, KDR, MMP2, PPARD, RORC, SRC |
6.00164 |
[BP] GO:0044281 |
small molecule metabolic process
|
ADORA2A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PPARD, TYR, XDH |
5.87653 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PPARD, RORC, SRC |
5.81237 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, ADORA2A, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIM1, PPARD, PTPN1, SRC, TERT |
5.7307 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.6897 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESRRA, FABP3, FABP4, FLT3, GLRA1, HSD17B2, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR |
5.66793 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
5.60476 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC, SRC |
5.57417 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
5.49692 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
5.47041 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, PPARD, SRC, TYR |
5.43254 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, FABP4, FLT3, GLRA1, IGF1R, KDR, MMP2, MMP9, PPARD, PTPN1, RORC, SRC, TERT, TOP2A |
5.29346 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
5.00457 |
[BP] GO:0009636 |
response to toxic substance
|
ADORA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, GLRA1, KDR, SRC |
4.8865 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADORA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1, HSD17B2, PPARD |
4.84083 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.83168 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADORA2A, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, PPARD, RORC, SRC, TYR |
4.83168 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC, SRC |
4.8135 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, GLRA1, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, RORC, SRC, TYR |
4.8013 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, DNMT1, ESR1, GLRA1, IGF1R, MMP2, MMP9, PPARD, RORC, SRC |
4.78234 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
4.7517 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA2A, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARD, SRC, TERT |
4.7517 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.7306 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, SRC, TERT |
4.69218 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARD, SRC, TERT |
4.68374 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADORA2A, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.67791 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SRC |
4.617 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.59384 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.55404 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADORA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
4.48813 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.48579 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARD, SRC, TERT |
4.39942 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, PIM1, SRC |
4.38914 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, ESR1, PPARA, RORC, SRC, TOP2A |
4.26566 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
4.25116 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADORA2A, APP, CYP19A1, DYRK1A, ESR1, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
4.24338 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, PPARD, SRC, XDH |
4.17878 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.14973 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARD, TERT |
4.0665 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
4.05044 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PPARD, SRC, TERT |
4.02394 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, PPARD, TYR, XDH |
4.0193 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, GLRA1, HSD17B2, MMP2, MMP9, PPARD, SRC, TOP2A |
4.0193 |
[BP] GO:0010243 |
response to organonitrogen compound
|
ADORA2A, AKR1B1, APEX1, APP, DNMT1, FABP3, FLT3, GLRA1, IGF1R, MMP2, PPARA, SRC, TYR |
4.0193 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, PPARD |
3.92013 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, GLRA1, MMP9, TERT |
3.92013 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, PPARD, SRC, TYR |
3.88588 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
3.88433 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, FABP3, GLRA1, PPARA, PPARD |
3.81396 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ADORA2A, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, PPARD, PTPN1, SRC, XDH |
3.79229 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.74744 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADORA2A, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
3.731 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CYP19A1, HCAR2, MMP12, PPARD, SRC, TERT |
3.70325 |
[BP] GO:1901698 |
response to nitrogen compound
|
ADORA2A, AKR1B1, APEX1, APP, DNMT1, FABP3, FLT3, GLRA1, IGF1R, MMP2, PPARA, SRC, TYR |
3.70201 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.70142 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.70142 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.69168 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PPARD, PTPN1, SRC, XDH |
3.66845 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, RORC, SRC |
3.64974 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, SRC, TERT |
3.63808 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADORA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
3.58714 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADORA2A, BCL2, CYP19A1, DYRK1A, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
3.58714 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, SRC, TERT |
3.56243 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ADORA2A, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, PPARD, PTPN1, SRC, XDH |
3.55926 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.54478 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, PPARD |
3.53763 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA2A, ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.53763 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.50941 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR |
3.50285 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, PPARD, SRC, TERT |
3.47907 |
[BP] GO:0042493 |
response to drug
|
ABCB1, ADORA2A, AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, FABP3, GLRA1, KDR, SRC |
3.47907 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.43219 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADORA2A, APP, AURKB, DNMT1, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A |
3.4179 |
[BP] GO:0001973 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.41133 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, SRC, TERT, XDH |
3.38834 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADORA2A, CA2, CA7 |
3.34972 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PPARD, SRC, TERT |
3.3374 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
3.31302 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.28111 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28111 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, ADORA2A, BCL2, CA2, CA7, KDR, SRC |
3.28111 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC |
3.20423 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, PPARD, TYR |
3.17872 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA2A, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, PPARD |
3.1698 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADORA2A, APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PPARD, RORC, SRC, TERT, TOP2A |
3.16893 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADORA2A, ALPL, APP, AXL, BCL2, CDC25B, CYP1A1, ESR1, ESRRB, FABP4, FLT3, GLO1, KDR, MET, MMP2, MMP9, PPARD, RORC, SRC, TERT, TOP2A |
3.13463 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, ESR1, FLT3, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, SRC, TOP2A, TYR, XDH |
3.13081 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, ADORA2A, CA2, CA7 |
3.11897 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DYRK1A, ESR1, ESR2, GLRA1, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
3.11897 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DYRK1A, ESR1, ESR2, GLRA1, IGF1R, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
3.10549 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
3.07919 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, GLRA1, HSD17B2, KDR, MMP2, SRC |
3.07842 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, FLT3, KDR, MET, PPARD, PTPN1, SRC, XDH |
3.05214 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.04984 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADORA2A, APP, AXL, BCL2, CA2, CA7, CYP19A1, HCAR2, MMP12, MMP9, PPARA, PPARD, PTPN1, SRC, TERT |
3.04101 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
ADORA2A, APEX1, APP, AURKB, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, KDR, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
3.04018 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
3.03306 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.98131 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADORA2A, CA2, CA7 |
2.98131 |
[BP] GO:0051172 |
None
|
ADORA2A, APEX1, APP, AURKB, CSNK2A1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, IGF1R, MMP12, MMP9, PPARA, PPARD, PTPN1, RORC, SRC, TERT, XDH |
2.98021 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA2A, ADORA3, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.97732 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, MMP2, PPARA, PPARD, SRC, TERT, TYR |
2.94947 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91924 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.91924 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
2.91924 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.90158 |
[BP] GO:0042752 |
None
|
ADORA1, ADORA2A, PPARA, RORC, TOP2A |
2.8152 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, ADORA2A, HCAR2, MMP12, PPARD, SRC |
2.8152 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PPARD, SRC |
2.81288 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADORA2A, AURKB, BCL2, CA2, CA7, HCAR2, KDR, SRC |
2.79833 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, MMP12, PPARA, PPARD |
2.78065 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
2.77119 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.74652 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADORA2A, APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PPARA, PPARD, RORC, SRC, TERT, TOP2A |
2.73389 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, PPARD |
2.72428 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, ADORA2A, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.69104 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, PPARA, PPARD |
2.68243 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADORA2A, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARD, PTPN1, SRC, TERT, XDH |
2.67333 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.66622 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA2A, ADORA3, APP, AXL, BCL2, CA2, CYP1B1, ESR1, ESRRA, ESRRB, GLRA1, HCAR2, KDR, MET, MMP12, MMP9, PIM1, PPARD, SRC, TERT, XDH |
2.66622 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, PPARD |
2.66119 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.65728 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, ADORA2A, CYP19A1, HCAR2, MMP12, PPARD, SRC |
2.64008 |
[BP] GO:0051253 |
None
|
APEX1, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, MMP12, PPARA, PPARD, RORC, SRC, TERT |
2.60348 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, PPARD |
2.59627 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.59627 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, MMP9, PTPN1, SRC, XDH |
2.59627 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, ADORA2A, CYP19A1, ESR1, FABP4, MMP12, MMP2, PPARA, PPARD, PTPN1, SRC |
2.59164 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, GLRA1, KDR, SRC |
2.58517 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.5564 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.55619 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, GLRA1, IGF1R, MMP2, SRC |
2.55619 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA2A, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC |
2.55109 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, ADORA2A, CYP19A1, PPARA, PPARD |
2.54541 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, PPARD, RORC, SRC, TERT, TOP2A |
2.54541 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.5408 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.5408 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.5408 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, MET, PPARA, PPARD |
2.51546 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.51301 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA2A, ADORA3, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.49086 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, PPARD |
2.49086 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PPARD |
2.49086 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.48689 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA2A, ADORA3, APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.47312 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADORA2A, APP, CA2, CA7 |
2.47128 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.47128 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.46515 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7 |
2.45847 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADORA2A, APP, BACE1, CA2, CA7 |
2.45847 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.45631 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.45631 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.45556 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, DNMT1, ESR1, FLT3, GLRA1, IGF1R, MMP2, SRC |
2.43649 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, PPARD |
2.41993 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.41983 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.41983 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.41044 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.40339 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADORA2A, APP, AXL, BCL2, CA2, CYP1B1, ESRRB, HCAR2, KDR, MET, MMP12, MMP9, PIM1, SRC, TERT |
2.39696 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
ADORA2A, BCL2, KDR, SRC |
2.3909 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARD, TERT |
2.38567 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, GLRA1, IGF1R, MMP2, SRC |
2.38296 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.37682 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37682 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.37535 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA2A, ADORA3, APP, BCL2, CYP1B1, FABP3, PPARD, TERT, XDH |
2.35703 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADORA2A, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.34039 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.32701 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.3123 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3123 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.30262 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.2892 |
[BP] GO:0010629 |
None
|
APP, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, KDR, MMP12, PPARA, PPARD, RORC, SRC, TERT, XDH |
2.27326 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.27075 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, SRC, TOP2A |
2.27075 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.21184 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20859 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.18444 |
[BP] GO:0050714 |
None
|
ACHE, ADORA2A, HCAR2, MMP12, PPARD, SRC |
2.17403 |
[BP] GO:0045934 |
None
|
APEX1, AURKB, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, FABP4, MMP12, PPARA, PPARD, RORC, SRC, TERT |
2.17154 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA2A, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, FABP4, FLT3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
2.15865 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.15779 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.15345 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.14385 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, GLRA1, MMP9 |
2.14136 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, SRC |
2.13547 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.1012 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PPARD |
2.1012 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.09914 |
[BP] GO:1903532 |
None
|
ACHE, ADORA2A, CYP19A1, HCAR2, MMP12, PPARD, SRC |
2.09138 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.08587 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06475 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.05794 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, PPARD, TYR |
2.05024 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ADORA2A, CYP19A1, ESR1, FABP4, KDR, MET, MMP12, PPARA, PPARD |
2.03591 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.89917 |
[CC] GO:0099056 |
None
|
ADORA1, ADORA2A |
2.5408 |
[CC] GO:0098889 |
None
|
ADORA1, ADORA2A |
2.5408 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADORA2A, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.26881 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AURKB, BACE1, BCL2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, GLRA1, IGF1R, KDR, MMP12, MMP2, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.15345 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, BCL2, CA4, CYP19A1, FLT3, GLRA1, KDR, PTPN1, XDH |
2.04745 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA2A, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CSNK2A1, ESR1, FLT3, GLO1, GLRA1, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TERT |
2.03591 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, TYR, XDH |
17.4179 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GLRA1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
11.2207 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PPARA, PPARD, PTPN1, RORC |
9.10799 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.17591 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, FLT3, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TYR, XDH |
8.06452 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, TERT, TOP2A, TYR, XDH |
7.63445 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, ESR1, ESR2, ESRRA, ESRRB, GLO1, GLRA1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARD, PTPN1, RORC, TERT, TOP2A, TYR, XDH |
7.26515 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.83769 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.83769 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARD, RORC |
6.43276 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.81237 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.16155 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.5638 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, FLT3, GLRA1, IGF1R, KDR, MET, PIM1, PPARA, PPARD, SRC, TOP2A |
4.55404 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, TYR, XDH |
4.18445 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.17878 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, PPARA, PPARD, RORC |
3.95306 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.88433 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.81396 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA2A, ADORA3 |
3.70142 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADORA2A, AOX1, APP, BCL2, CSNK2A1, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, TERT, TOP2A, TYR, XDH |
3.69376 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.6478 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
3.62234 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.60491 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, MET, SRC |
3.60491 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA2A, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, PPARA, PPARD, RORC |
3.38242 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, XDH |
3.23404 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA2A, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, PPARA, PPARD, RORC |
3.22163 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
3.18948 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.17872 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, GLRA1, HSD17B1, IGF1R, KDR, MET, PIM1, PPARD, SRC, TOP2A, XDH |
3.11897 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, PPARD, RORC |
3.09784 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA2A, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GLRA1, HCAR2, IGF1R, KDR, MET, PPARA, PPARD, RORC |
2.91924 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91924 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.89938 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.87126 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.86873 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, PPARD, SRC, TERT |
2.86873 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.64624 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.55109 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.51301 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.49086 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.38567 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.3123 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PPARD, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.29892 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA2A, ADORA3 |
2.28482 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.26368 |
[MF] GO:0043565 |
None
|
APEX1, BCL2, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, PPARD, RORC, TERT |
2.25409 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.19773 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.13189 |
[MF] GO:0043168 |
anion binding
|
ABCB1, AOX1, APP, AURKB, AXL, CSNK2A1, DYRK1A, FABP3, FABP4, FLT3, GLRA1, HSD17B1, IGF1R, KDR, MET, PIM1, PPARD, SRC, TOP2A, XDH |
2.09351 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, SRC, XDH |
2.08415 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.06426 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.05044 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.03402 |